WellCare's stock jumps 23% after Centene announces merger valued at $17.3 billion

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

WellCare's stock jumps 23% after Centene announces merger worth $17.3 billion

Health-care company Centene Corp. CNC, -3.86% on Wednesday announced plans to purchase managed-care provider WellCare Health Plans Inc. WCG, -3.93% St. Louis-based Centene said it would buy WellCare, based in Tampa, Florida, for $305.39 per share, with the deal valued at $17.3 billion. Bloomberg News on Tuesday reported that the health-care companies were in merger talks.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

thanks for updates ODPP

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 3. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Levi Strauss, Valued At $6.6 Billion, Is Making A Comeback As A Public CompanyThe 165-year-old company that invented blue jeans still makes most of its money from men’s pants, but that's changing. Now it's time for Levi Ackerman to make a comeback as humanity's strongest My favorite jeans Levi's jeans for life
La source: Forbes - 🏆 394. / 53 Lire la suite »

Boeing has lost $40 billion-plus in market value since Ethiopia crashBoeing is having a horrible month. looking for logos of your company / business / website /brand or other events ....? go and order now And the 401k gamble continues. Huh! safetyMatters
La source: CNN - 🏆 4. / 95 Lire la suite »

Biogen scraps Alzheimer drug trials, wiping $17 billion off its market valueReuters - Biogen and partner Eisai Co Ltd are ending two late-stage trials for t... This sucks. Did they forget? 😂
La source: Reuters - 🏆 2. / 97 Lire la suite »